EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment

TNM Classification of Malignant Tumours

1987 • 16,209 citations

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

2004 • 11,185 citations

EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

2004 • 9,201 citations

EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

2004 • 4,293 citations

TNM Classification of Malignant Tumours

2003 • 3,865 citations

Oncogenic kinase signalling

2001 • 3,632 citations

Epidermal growth factor receptor: mechanisms of activation and signalling

2003 • 1,514 citations

A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

2001 • 988 citations

Structural alterations of the epidermal growth factor receptor gene in human gliomas.

1992 • 853 citations

EGF receptor

1999 • 792 citations

Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

2004 • 749 citations

Requirement for c-ras proteins during viral oncogene transformation

1986 • 680 citations

Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.

2000 • 667 citations

The role of protein phosphorylation in human health and disease.

2001 • 596 citations

The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling

1997 • 591 citations

FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets

2003 • 541 citations

Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.

1993 • 482 citations

Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.

2001 • 455 citations

Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.

1997 • 404 citations

The ErbB/HER receptor protein-tyrosine kinases and cancer

2004 • 390 citations

The epidermal growth factor receptor–tyrosine kinase: A promising therapeutic target in solid tumors

2003 • 299 citations

ErbB-targeted therapeutic approaches in human cancer

2003 • 217 citations

Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC

2003 • 213 citations

Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies

2003 • 204 citations

Constitutive Activation of c-Jun N-terminal Kinase by a Mutant Epidermal Growth Factor Receptor

1998 • 163 citations

p53 Alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes

1994 • 133 citations

Bronchioloalveolar carcinoma.

1996 • 123 citations

BRONCHIOLOALVEOLAR LUNG CARCINOMAS: K-ras MUTATIONS ARE CONSTANT EVENTS IN THE MUCINOUS SUBTYPE

1996 • 110 citations

The role of EGFR inhibitors in nonsmall cell lung cancer

2004 • 110 citations

Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung

1999 • 81 citations

The ErbB/HER receptor protein-tyrosine kinases and cancer*1

2004 • 79 citations

The spectrum and significance of bronchioloalveolar carcinomas.

1988 • 74 citations

Mutant Epidermal Growth Factor Receptors as Targets for Cancer Therapy

2002 • 70 citations

Detection of p53 Mutations by Single-strand Conformation Polymorphisms (SSCP) Gel Electrophoresis

1995 • 62 citations

EGF receptor as a therapeutic target

2003 • 58 citations

FHIT andp53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations

1998 • 52 citations

Bronchioloalveolar Carcinoma

2004 • 52 citations

Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity in the FHIT locus

1998 • 48 citations

Gefitinib (ZD1839) therapy for advanced bronchioloalveolar lung cancer (BAC): Southwest Oncology Group (SWOG) Study S0126

2004 • 47 citations

A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (“Iressa”¹

2003 • 45 citations

Non-isotopic silver-stained SSCP is more sensitive than automated direct sequencing for the detection of PTEN mutations in a mixture of DNA extracted from normal and tumor cells

2001 • 45 citations

The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells

2003 • 43 citations

[41] Purification of the receptor for epidermal growth factor from A-431 cells: its function as a tyrosyl kinase

1983 • 35 citations

Successful treatment of persistent bronchorrhea by gefitinib in a case with Recurrent Bronchioloalveolar Carcinoma: a case report.

2003 • 25 citations

Clinical experience with the HER1/EGFR tyrosine kinase inhibitor erlotinib.

2003 • 23 citations

Highlights from the Tenth World Conference on Lung Cancer

2004 • 16 citations

Detection of DNA mutations in acid formalin-fixed paraffin-embedded archival tumor specimens by polymerase chain reaction-single strand conformation polymorphism analysis.

1995 • 9 citations